EMPLICITI 400 mg/1

Elotuzumab is a prescription medication used in combination with other drugs for certain types of cancer. This lyophilized powder for solution is administered intravenously and is available in a 400 mg/1 strength.

Elotuzumab is primarily used in combination with other medications for the treatment of multiple myeloma, a type of cancer affecting plasma cells. It works by targeting specific proteins on cancer cells to help the immune system attack them more effectively. Patients often wonder, 'What is elotuzumab used for?' and the answer lies in its role as a targeted therapy for specific blood cancers.

Common effects of elotuzumab may include infusion reactions such as fever, chills, and fatigue. Some patients may also experience nausea, diarrhea, or weakness. These effects can vary and are not experienced by everyone who takes the medication.

Elotuzumab should be handled with care and administered under the supervision of a healthcare professional. It is important to follow all safety guidelines and storage instructions provided by the manufacturer. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Elotuzumab may interact with other medications, including those that suppress the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy or safety of elotuzumab.